Abstract:The AMP-activated protein kinase(AMPK) serves as a fuel gauge activated under metabolic stresses which is usually accompanied by increasing intracellular levels of AMP or the ration of AMP to ATP.As a result,AMPK stimulates fatty acid oxidation to generate more ATP and inhibits ATP-consuming processes in coping with stresses and assuring acute cell surviving programs.Since several clinically used anti-diabetic drugs activate AMPK,it is regarded as a promising and effective drug target for type 2 diabetes.Using 5-aminoimidazole-4-carboxamide 1-D-ribonucleoside(AICAR),a cell permeable agent that is phosphorylated inside cells and converted to ZMP,an analog of AMP and a canonical pharmacological AMPK activator,we explored the effect of AMPK on energy metabolism and the insulin signaling pathway in adipocytes.Our results showed that when AMPK was activated,the concentration of malonyl-CoA,an inhibitor of fatty acid oxidation and an intermediate in fatty acid synthesis,diminished by 80%.They also showed that AICAR activated AMPK in differentiated 3T3-F442a adipocytes and enhanced insulin stimulated Akt/PKB activation as well as GSK3βphosphorylation.In contrast,the ability of insulin to activate mTOR,a critical kinase for protein synthesis,was impaired by preincubation of cells with AICAR.This led to a decrease in the phosphorylation of downstream effectors of mTOR,including p70S6K,S6 and 4E-BP1.Furthermore,our results revealed that AMPK directly phosphorylated mTOR and inhibited its autokinase activity in vitro and that AMPK activation by 2-deoxide glucose caused an inhibition of mTOR in MEF cells deficient in TSC2.Thus,our results for the first time demonstrate that AMPK phosphorylates mTOR which leads to the inhibition of its kinase activity and indicate that AMPK regulates mTOR at multiple levels.Collectively,these studies suggest that AMPK exerts a global effect on energy metabolism in adipocytes in which it inhibits both fatty acid and protein synthesis and stimulates fatty acid oxidation.

The Energy Sensing Lkb1-Ampk Alpha 1 Pathway Regulates Igf1 Secretion And Consequent Activation Of The Igf1r-Pkb Pathway In Primary Hepatocytes

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene

Disruption of the AMPK-TBC 1 D 1 Nexus Increases Lipogenic Gene Expression and Causes Obesity in Mice Via Promoting IGF 1 Secretion

The Role of AMPK in Regulation of the Insulin Signal Transduction Pathway

Insulin-like Growth Factor Binding Protein 1 Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease

AMPK-dependent Regulation of GLP1 Expression in L-like Cells.

Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy.

AMPK-mTORC1 pathway mediates hepatic IGFBP-1 phosphorylation in glucose deprivation

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

AMPK Activation Prevents Excess Nutrient-Induced Hepatic Lipid Accumulation by Inhibiting Mtorc1 Signaling and Endoplasmic Reticulum Stress Response.

Suppression of the Mtorc1/stat3/notch1 Pathway by Activated AMPK Prevents Hepatic Insulin Resistance Induced by Excess Amino Acids.

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

ETNPPL Modulates Hyperinsulinemia‐induced Insulin Resistance Through the SIK1/ROS‐mediated Inactivation of the PI3K/AKT Signaling Pathway in Hepatocytes

Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming

Amp-Activated Protein Kinase Alpha 1 Protects Against Diet-Induced Insulin Resistance And Obesity

Glucagon-like peptide-1 receptor mediates the improvement in glycolipid metabolism disorder via AKT and AMPK signalling pathways in L02 cells with insulin resistance

Abnormal Expression of Insulin-Like Growth Factor-I Receptor in Hepatoma Tissue and Its Inhibition to Promote Apoptosis of Tumor Cells

Energy-Dependent Modulation of Glucagon-Like Signaling in Drosophila via the AMP-Activated Protein Kinase

Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes

IGF-1R Down Regulates the Sensitivity of Hepatocellular Carcinoma to Sorafenib Through the PI3K / Akt and RAS / Raf / ERK Signaling Pathways